human adiponectin

Subscribe to Selected New Research on human adiponectin

5 relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Also Known As:

adiponectin, human; ACDC protein, human; ACRP30 protein, human; GBP28 protein, human; adipocyte complement-related protein 30 kDa, human; adipocyte, C1Q and collagen domain containing protein, human; adiponectin protein, human; adipose most abundant gene transcript 1, human; apM-1 protein, human; apM1 adipose-specific protein, human; gelatin-binding protein 28, human

Bio-Agent Context: Research Results

Experts

1.	Yang, Baofeng: 1 article (09/2007)
2.	Zhao, Jessica: 1 article (09/2007)
3.	Gasser, Jessica: 1 article (09/2007)
4.	Zhao, Allan Z: 1 article (09/2007)
5.	Li, Fanghong: 1 article (09/2007)
6.	Cong, Li: 1 article (09/2007)
7.	Baroni, Marco Giorgio: 1 article (03/2004)
8.	Di Mario, Umberto: 1 article (03/2004)
9.	Leonetti, Frida: 1 article (03/2004)
10.	Arca, Marcello: 1 article (03/2004)

Related Diseases

1.	Type 2 Diabetes Mellitus (MODY) 02/01/2006 - "Some of the common polymorphisms in the promoter region, exon and intron 2, and the rare nonsynonymous mutations in exon 3 of the human adiponectin gene were repeatedly shown in many studies from many different ethnic populations to associate with the phenotypes related to body weight, glucose metabolism, insulin sensitivity, and risk of type 2 diabetes mellitus and coronary artery disease. " Order ALL the reference details at left...
2.	Coronary Artery Disease (Coronary Atherosclerosis) 02/01/2006 - "Some of the common polymorphisms in the promoter region, exon and intron 2, and the rare nonsynonymous mutations in exon 3 of the human adiponectin gene were repeatedly shown in many studies from many different ethnic populations to associate with the phenotypes related to body weight, glucose metabolism, insulin sensitivity, and risk of type 2 diabetes mellitus and coronary artery disease. " Order ALL the reference details at left...
3.	Body Weight (Weight, Body) 02/01/2006 - "Some of the common polymorphisms in the promoter region, exon and intron 2, and the rare nonsynonymous mutations in exon 3 of the human adiponectin gene were repeatedly shown in many studies from many different ethnic populations to associate with the phenotypes related to body weight, glucose metabolism, insulin sensitivity, and risk of type 2 diabetes mellitus and coronary artery disease. " Order ALL the reference details at left...
4.	Obesity 08/01/2007 - "BACKGROUND: Genetic variations of the human adiponectin gene are associated with metabolic phenotypes, including obesity, insulin sensitivity, and diabetes. " 08/01/2003 - "BACKGROUND: The human adiponectin gene has been implicated in the pathophysiology of obesity, type II diabetes mellitus, dyslipidemia and atherosclerosis. " Order ALL the reference details at left...
5.	Atherosclerosis (Atheroma) 08/01/2003 - "BACKGROUND: The human adiponectin gene has been implicated in the pathophysiology of obesity, type II diabetes mellitus, dyslipidemia and atherosclerosis. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Insulin (Novolin)
2.	Glucose (Dextrose)

Best Treatments:
Research Summary Report
on Type 2 Diabetes Mellitus

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 666 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>